Deadline: 31-May-23
RTW Charitable Foundation is proud to announce an open call for its Research Grant Cycle to support work aimed at developing therapeutics for ultrarare diseases.
The mission of the RTW Charitable Foundation is to power rare-disease research, medical innovation, and humanitarian collaborations to improve the health of underserved communities.
Funding Information
- The 2023 Grants will provide up to $150,000 for one year to support translational projects that bridge the gap between proof-of-concept studies in animal models and preclinical safety/toxicology studies.
Eligibility Criteria
The Request for Proposals is open to:
- Any scientists or clinicians affiliated with a higher-education research institution or healthcare organization anywhere in the world (projects led by patient organizations are also welcome)
- Diseases that affect fewer than 2000 patients worldwide (monogenetic, life-threatening conditions affecting fewer than 300 patients worldwide preferred)
- Diseases for which no commercial drug-development programs exist
- Projects in any therapeutic area
- Projects that involve any clinically validated therapeutic modality (gene-replacement and antisense oligonucleotide-based therapies preferred)
- Projects for which there is evidence that the proposed therapeutic modality works in an animal model (or in another suitable system)
For more information, visit RTW Charitable Foundation.